Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -2.75x is 54% above its 5-year average of -5.97x, near the high end of its 5-year range (-59.56x–4.94x).
4.65% above its 12-month average of -2.88x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -3.03x.
INTEREST COVERAGE RATIO
-2.75x
INTEREST COVERAGE RATIO AVG TTM
-2.88x
INTEREST COVERAGE RATIO AVG 3Y
-4.86x
INTEREST COVERAGE RATIO AVG 5Y
-5.97x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+4.65%
CURRENT VS 3Y AVG
+43.39%
CURRENT VS 5Y AVG
+53.96%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 524 covered companies
CURRENT VS SECTOR MEDIAN
+56.86%
vs the sector median at left
Sutro Biopharma, Inc.
Market Cap
$140.51M
Interest Coverage Ratio
-2.75x
TTM Avg
-2.88x
3Y Avg
-4.86x
5Y Avg
-5.97x
Market Cap
$143.75M
Interest Coverage Ratio
-8.06x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$140.49M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$143.25M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$139.08M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$137.05M
Interest Coverage Ratio
N/A
TTM Avg
346.24x
3Y Avg
936.28x
5Y Avg
577.46x
Market Cap
$137.36M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$146.98M
Interest Coverage Ratio
-29.32x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sutro Biopharma, Inc. (STRO) | $140.51M | -2.75x | -2.88x | -4.86x | -5.97x |
| Fortress Biotech, Inc. (FBIOP)vs › | $143.75M | -8.06x | N/A | N/A | N/A |
| Immuneering Corporation (IMRX)vs › | $140.49M | N/A | N/A | N/A | N/A |
| Protara Therapeutics, Inc. (TARA)vs › | $143.25M | N/A | N/A | N/A | N/A |
| Alpha Cognition Inc (ACOG)vs › | $139.08M | N/A | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $143.60M | -49.05x | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.05M | N/A | 346.24x | 936.28x | 577.46x |
| Atrium Therapeutics, Inc. (RNA)vs › | $137.36M | N/A | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.98M | -29.32x | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $135.61M | N/A | N/A | N/A | N/A |
Interest Coverage
-2.8x
Debt/Equity
N/A
Current Ratio
3.32
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -3.03x |
| 2026-03-31 | -3.13x |
| 2025-12-31 | -3.26x |
| 2025-09-30 | -4.66x |
| 2025-06-30 | -0.35x |
| 2025-03-31 | -6.44x |
| 2024-12-31 | -7.51x |
| 2024-09-30 | -8.59x |
| 2024-06-30 | -5.38x |
| 2024-03-31 | -6.02x |
| 2023-12-31 | 4.94x |
| 2023-09-30 | -5.07x |
| 2023-06-30 | -13.76x |
| 2023-03-31 | -14.15x |
| 2022-09-30 | -7.61x |
| 2022-06-30 | -32.62x |
| 2022-03-31 | -59.56x |
| 2021-12-31 | -57.25x |
| 2021-09-30 | -42.29x |
| 2021-06-30 | -11.58x |
| 2021-03-31 | -22.16x |
| 2020-09-30 | -4.58x |
| 2020-06-30 | -5.56x |
| 2020-03-31 | -18.16x |
| 2019-12-31 | -18.09x |
| 2019-09-30 | -11.16x |
| 2019-06-30 | -11.11x |
| 2019-03-31 | -12.30x |
| 2018-12-31 | -7.72x |
| 2018-09-30 | -21.03x |
| 2018-03-31 | -30.56x |
| 2017-12-31 | -40.23x |
| 2017-09-30 | -4.53x |
